To reflect the change, the company will now be called MaxRS Ventures plc.
Michael Sassano, CEO of Somai Pharmaceuticals reflects on Q3 2022.
AIM-listed cash shell company UK SPAC Plc has confirmed that the Financial Conduct Authority (FCA) has approved the prospectus of
BDSA has updated its cannabis market forecast.
Get up to date with the latest financial results from Jazz Pharma, Flora Growth, Khiron, MGC Pharma, CBD of Denver and Tilray.
Cannabis Europa explored the pros and cons of being a first mover in the nascent European industry.
Analysis from Prohibition Partners underscores how the UK’s inability to embrace the industry could come at a significant economic cost.
A new report from Fact.MR shows the market will grow at a CAGR of 31 per cent until 2032.
The CBX Stock Exchange is a B2B trading platform for raw cannabis materials.
The sales estimates were based on a survey of research firms covering the financial outlook of Aurora.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
